All IV treatments are administered by a registered nurse after the assessment of your health history
Within a month, I felt like a new person
GLP-1 Drugs Changed Peptide Manufacturing Forever: Here Is What the Industry Is Doing to Keep Up In June 2021, the FDA approved Wegovy, the semaglutide-based obesity treatment from Novo Nordisk, and the global pharmaceutical industry entered a chapter it was entirely unprepared for
By: Cami Eastman, RDN, LD on 02/26/2026 As more people in midlife turn to GLP-1 medications for metabolic support, questions are emerging about how these drugs interact with hormone replacement therapy (HRT), what the long-term effects may be for postmenopausal bodies, and what nutritional strategies are most important to protect health
Front Immunol (2022) 13:772446